Conditions:
This study is based on the hypothesis that by increasing N-methyl-D-aspartic acid (NMDA) receptor function in the brain and thereby increasing the capacity of the brain to both form new connections and strengthen existing connections, schizophrenic patients may derive both greater and sustained benefit from cognitive retraining.
Dates: September 2002 -
Study Status: Recruiting
Ages Eligible: 18 Years - 65 Years
Gender Eligible: Both
Inclusion Criteria:
- Diagnosis of schizophrenia or schizoaffective disorder
Exclusion
- Pregnant or lactating
Sponsors:
Phase: Phase 3
First Received: September 13, 2005
Last Updated: August 30, 2010
Clinicaltrials.gov ID:
NCT00237809
Study HIC # 0301023594
Conditions:
Interventions: Drug: D-serine;
Behavioral: Cognitive retraining
This study is based on the hypothesis that by increasing N-methyl-D-aspartic acid (NMDA) receptor function in the brain and thereby increasing the capacity of the brain to both form new connections and strengthen existing connections, schizophrenic patients may derive both greater and sustained benefit from cognitive retraining.
Dates: September 2002 -
Study Status: Recruiting
Ages Eligible: 18 Years - 65 Years
Gender Eligible: Both
Inclusion Criteria:
- Diagnosis of schizophrenia or schizoaffective disorder
Exclusion
- Pregnant or lactating
Sponsors:
Phase: Phase 3
First Received: September 13, 2005
Last Updated: August 30, 2010
Clinicaltrials.gov ID:
NCT00237809
Study HIC # 0301023594
Rajiv Radhakrishnan, MD
203-932-5711 Ext. 3921
rajiv.radhakrishnan@yale.edu
Perry, Edward Belk Jr
Principal Investigator
HIC # 0805003779